261 related articles for article (PubMed ID: 29452636)
1. Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling.
Goncharov T; Hedayati S; Mulvihill MM; Izrael-Tomasevic A; Zobel K; Jeet S; Fedorova AV; Eidenschenk C; deVoss J; Yu K; Shaw AS; Kirkpatrick DS; Fairbrother WJ; Deshayes K; Vucic D
Mol Cell; 2018 Feb; 69(4):551-565.e7. PubMed ID: 29452636
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity.
Damgaard RB; Nachbur U; Yabal M; Wong WW; Fiil BK; Kastirr M; Rieser E; Rickard JA; Bankovacki A; Peschel C; Ruland J; Bekker-Jensen S; Mailand N; Kaufmann T; Strasser A; Walczak H; Silke J; Jost PJ; Gyrd-Hansen M
Mol Cell; 2012 Jun; 46(6):746-58. PubMed ID: 22607974
[TBL] [Abstract][Full Text] [Related]
3. XIAP mediates NOD signaling via interaction with RIP2.
Krieg A; Correa RG; Garrison JB; Le Negrate G; Welsh K; Huang Z; Knoefel WT; Reed JC
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14524-9. PubMed ID: 19667203
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
Hrdinka M; Schlicher L; Dai B; Pinkas DM; Bufton JC; Picaud S; Ward JA; Rogers C; Suebsuwong C; Nikhar S; Cuny GD; Huber KV; Filippakopoulos P; Bullock AN; Degterev A; Gyrd-Hansen M
EMBO J; 2018 Sep; 37(17):. PubMed ID: 30026309
[TBL] [Abstract][Full Text] [Related]
5. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
[TBL] [Abstract][Full Text] [Related]
6. Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling.
Damgaard RB; Fiil BK; Speckmann C; Yabal M; zur Stadt U; Bekker-Jensen S; Jost PJ; Ehl S; Mailand N; Gyrd-Hansen M
EMBO Mol Med; 2013 Aug; 5(8):1278-95. PubMed ID: 23818254
[TBL] [Abstract][Full Text] [Related]
7. The inositol phosphatase SHIP-1 inhibits NOD2-induced NF-κB activation by disturbing the interaction of XIAP with RIP2.
Condé C; Rambout X; Lebrun M; Lecat A; Di Valentin E; Dequiedt F; Piette J; Gloire G; Legrand S
PLoS One; 2012; 7(7):e41005. PubMed ID: 22815893
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses.
Tigno-Aranjuez JT; Asara JM; Abbott DW
Genes Dev; 2010 Dec; 24(23):2666-77. PubMed ID: 21123652
[TBL] [Abstract][Full Text] [Related]
9. E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDP.
Bist P; Cheong WS; Ng A; Dikshit N; Kim BH; Pulloor NK; Khameneh HJ; Hedl M; Shenoy AR; Balamuralidhar V; Malik NBA; Hong M; Neutzner A; Chin KC; Kobayashi KS; Bertoletti A; Mortellaro A; Abraham C; MacMicking JD; Xavier RJ; Sukumaran B
Nat Commun; 2017 Jun; 8():15865. PubMed ID: 28656966
[TBL] [Abstract][Full Text] [Related]
10. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.
Tao M; Scacheri PC; Marinis JM; Harhaj EW; Matesic LE; Abbott DW
Curr Biol; 2009 Aug; 19(15):1255-63. PubMed ID: 19592251
[TBL] [Abstract][Full Text] [Related]
11. Inflammation NODs to Antagonists of RIP2-XIAP Interaction.
Xia S; Fu TM; Wu H
Mol Cell; 2018 Feb; 69(4):535-536. PubMed ID: 29452633
[TBL] [Abstract][Full Text] [Related]
12. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
[TBL] [Abstract][Full Text] [Related]
13. Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis.
Yang S; Wang B; Humphries F; Jackson R; Healy ME; Bergin R; Aviello G; Hall B; McNamara D; Darby T; Quinlan A; Shanahan F; Melgar S; Fallon PG; Moynagh PN
Nat Immunol; 2013 Sep; 14(9):927-36. PubMed ID: 23892723
[TBL] [Abstract][Full Text] [Related]
14. A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy.
Homer CR; Kabi A; Marina-García N; Sreekumar A; Nesvizhskii AI; Nickerson KP; Chinnaiyan AM; Nuñez G; McDonald C
J Biol Chem; 2012 Jul; 287(30):25565-76. PubMed ID: 22665475
[TBL] [Abstract][Full Text] [Related]
15. RIP2 filament formation is required for NOD2 dependent NF-κB signalling.
Pellegrini E; Desfosses A; Wallmann A; Schulze WM; Rehbein K; Mas P; Signor L; Gaudon S; Zenkeviciute G; Hons M; Malet H; Gutsche I; Sachse C; Schoehn G; Oschkinat H; Cusack S
Nat Commun; 2018 Oct; 9(1):4043. PubMed ID: 30279485
[TBL] [Abstract][Full Text] [Related]
16. TNF-α-Induced NOD2 and RIP2 Contribute to the Up-Regulation of Cytokines Induced by MDP in Monocytic THP-1 Cells.
Chen X; Xiao Z; Xie X; Liu X; Jiang M; Yuan C; Yang L; Hu J
J Cell Biochem; 2018 Jul; 119(7):5072-5081. PubMed ID: 28639322
[TBL] [Abstract][Full Text] [Related]
17. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
Zhou Y; Hu L; Tang W; Li D; Ma L; Liu H; Zhang S; Zhang X; Dong L; Shen X; Chen S; Xue R; Zhang S
J Hematol Oncol; 2021 Jan; 14(1):9. PubMed ID: 33413510
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
Canning P; Ruan Q; Schwerd T; Hrdinka M; Maki JL; Saleh D; Suebsuwong C; Ray S; Brennan PE; Cuny GD; Uhlig HH; Gyrd-Hansen M; Degterev A; Bullock AN
Chem Biol; 2015 Sep; 22(9):1174-84. PubMed ID: 26320862
[TBL] [Abstract][Full Text] [Related]
19. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.
Abbott DW; Wilkins A; Asara JM; Cantley LC
Curr Biol; 2004 Dec; 14(24):2217-27. PubMed ID: 15620648
[TBL] [Abstract][Full Text] [Related]
20. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.
Heim VJ; Dagley LF; Stafford CA; Hansen FM; Clayer E; Bankovacki A; Webb AI; Lucet IS; Silke J; Nachbur U
EMBO Rep; 2020 Nov; 21(11):e50400. PubMed ID: 32954645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
